Articles related to Oncology, Surgical

Radiopharmaceuticals represent a burgeoning frontier in cancer treatment, offering targeted therapies that minimize collateral damage to healthy tissues.

Dr. Liangco’s book provides a unique glimpse into the personal and professional challenges faced by oncologists in resource-limited settings, emphasizing the stark realities of healthcare disparities.

Study reveals a correlation between key opinion leaders in oncology and higher industry payments, prompting calls for stronger regulations to address potential biases.

This phase 2 study underscores the challenges in enhancing therapeutic outcomes in metastatic castration-resistant prostate cancer with AZD4635 combined with immunotherapy, indicating a minimal PSA response among treated patients.

In cases of prostate cancer post-aquablation therapy, managing residual tissue and persistent PSA levels poses significant challenges for surgical intervention, as detailed by Dr. Edward M. Schaeffer.

Recent research indicates a rise in cancer mortality following the third dose of mRNA COVID-19 vaccines, especially in types linked to estrogen sensitivity. This underscores the need for ongoing surveillance and research into the long-term effects of mRNA vaccines on cancer progression.